BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19327809)

  • 1. Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant.
    Crisci E; Almanza H; Mena I; Córdoba L; Gómez-Casado E; Castón JR; Fraile L; Bárcena J; Montoya M
    Virology; 2009 May; 387(2):303-12. PubMed ID: 19327809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of different recombinant rabbit hemorrhagic disease virus-like particles carrying CD8+ T cell epitope from chicken ovalbumin (OVA).
    Chen M; Song Y; Fan Z; Jiang P; Hu B; Xue J; Wei H; Wang F
    Virus Res; 2014 Apr; 183():15-22. PubMed ID: 24457072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant VP60 in the form of virion-like particles as a potential vaccine against rabbit hemorrhagic disease virus.
    Gromadzka B; Szewczyk B; Konopa G; Fitzner A; Kesy A
    Acta Biochim Pol; 2006; 53(2):371-6. PubMed ID: 16733562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope.
    Cheong WS; Reiseger J; Turner SJ; Boyd R; Netter HJ
    Antiviral Res; 2009 Feb; 81(2):113-22. PubMed ID: 19007818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
    Woo WP; Doan T; Herd KA; Netter HJ; Tindle RW
    J Virol; 2006 Apr; 80(8):3975-84. PubMed ID: 16571814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response.
    Peacey M; Wilson S; Perret R; Ronchese F; Ward VK; Young V; Young SL; Baird MA
    Vaccine; 2008 Oct; 26(42):5334-7. PubMed ID: 18706958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation.
    Peacey M; Wilson S; Baird MA; Ward VK
    Biotechnol Bioeng; 2007 Dec; 98(5):968-77. PubMed ID: 17546687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th cell-independent immune responses to chimeric hemagglutinin/simian human immunodeficiency virus-like particles vaccine.
    Yao Q; Zhang R; Guo L; Li M; Chen C
    J Immunol; 2004 Aug; 173(3):1951-8. PubMed ID: 15265929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice.
    Li C; Liu F; Liang M; Zhang Q; Wang X; Wang T; Li J; Li D
    Vaccine; 2010 Jun; 28(26):4294-300. PubMed ID: 20433802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses.
    Moreno N; Mena I; Angulo I; Gómez Y; Crisci E; Montoya M; Castón JR; Blanco E; Bárcena J
    Sci Rep; 2016 Aug; 6():31844. PubMed ID: 27549017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes.
    Liu WJ; Liu XS; Zhao KN; Leggatt GR; Frazer IH
    Virology; 2000 Aug; 273(2):374-82. PubMed ID: 10915608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
    Storni T; Lechner F; Erdmann I; Bächi T; Jegerlehner A; Dumrese T; Kündig TM; Ruedl C; Bachmann MF
    J Immunol; 2002 Mar; 168(6):2880-6. PubMed ID: 11884458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained.
    Wherry EJ; Puorro KA; Porgador A; Eisenlohr LC
    J Immunol; 1999 Oct; 163(7):3735-45. PubMed ID: 10490969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
    Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
    Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose adenovirus vectored vaccine induces a potent and long-lasting immune response against rabbit hemorrhagic disease virus after parenteral or mucosal administration.
    Fernández E; Toledo JR; Chiong M; Parra F; Rodríguez E; Montero C; Méndez L; Capucci L; Farnós O
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):179-88. PubMed ID: 21621855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The recombinant rabbit hemorrhagic disease virus VP60 protein obtained from Pichia pastoris induces a strong humoral and cell-mediated immune response following intranasal immunization in mice.
    Farnós O; Rodríguez M; Chiong M; Parra F; Boué O; Lorenzo N; Colás M; Lleonart R
    Vet Microbiol; 2006 May; 114(3-4):187-95. PubMed ID: 16384666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
    Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.
    El-Gogo S; Staib C; Meyr M; Erfle V; Sutter G; Adler H
    Vaccine; 2007 May; 25(20):3934-45. PubMed ID: 17433507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.